Skip to main content
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Subscribe
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Additional Articles by the Author
Phoebe Starr
Lymphoma
Obinutuzumab Prolongs Survival in Follicular Lymphoma
Read More
Leukemia
Refining the Use of CAR T-Cells in Patients with Acute Lymphoblastic Leukemia
Read More
Breast Cancer
Extending Letrozole Therapy Beyond 5 Years in Early Breast Cancer Reduces Recurrence
Read More
Melanoma
Combination Immunotherapy Makes Progress in Advanced Melanoma
Read More
A New Paradigm Matching Targeted Therapy to Molecular Alterations Independent of Tumor Type
Read More
Prostate Cancer
Shorter Hypofractionated Therapy New Standard for Prostate Cancer
Read More
Emerging Therapies
Biosimilar to Trastuzumab Shows Equivalent Efficacy and Safety
Read More
Emerging Therapies
New Standard in Elderly Patients with Glioblastoma Based on Phase 3 Evidence
Read More
Aggressive End-of-Life Care Continues to Be Offered to Younger Patients with Cancer
Read More
Emerging Therapies
,
In the News
“Smart Bomb” First-in-Class Drug Rova-T Promising Novel Therapy for Small-Cell Lung Cancer
Read More
4
5
6
7
8
9
Page 7 of 9
Results 61 - 70 of 89